New Market Study Published: Mexico Pharmaceuticals & Healthcare Report Q2 2013
BMI View: Mexico's relatively low-cost business environment, growing domestic pharmaceutical market and the improving regulatory regime have made it an attractive market to multinationals. The improved performance by market regulator COFEPRIS has allowed Mexico to acquire a reputation for early, speedy approvals of medicines that meet urgent local epidemiological needs and allow direct access to other robust growing pharmaceutical markets in Latin America..
View full press release